# A Phase 1 Food Effect Study of TAK-536TCH Final Formulation Tablet

> **NCT02348658** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 12 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** TAK-536TCH

## Key facts

- **NCT ID:** NCT02348658
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2016-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02348658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02348658, "A Phase 1 Food Effect Study of TAK-536TCH Final Formulation Tablet". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02348658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*